Lozano, John Kyle H.
HRN: 22-24-47 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/05/2023
CEFUROXIME 1.5GM (VIAL)
09/05/2023
09/13/2023
IV
230mg
Q8
Pcap
Waiting Final Action
09/06/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
09/06/2023
09/12/2023
IV
35mg
Q24h
PCAP C
Waiting Final Action